What are the cervical cancer vaccines for women

The female cervical cancer vaccine is also called the human papillomavirus (HPV) vaccine. The purpose of vaccination with the human papillomavirus (HPV) vaccine is to prevent human papillomavirus infection, thereby preventing the occurrence of cervical cancer and genital warts. The human papillomavirus (HPV) vaccine includes the bivalent human papillomavirus vaccine, the quadrivalent human papillomavirus vaccine, the nine-valent human papillomavirus vaccine, etc. The specific introduction is as follows:

1. Bivalent human papillomavirus vaccine: The bivalent human papillomavirus vaccine is targeted at HPV16 and HPV18 types and is usually suitable for women aged 9 to 45 years old. Vaccination is carried out according to the immunization schedule of 0, 1 and 6 months.

2. Quadrivalent human papillomavirus vaccine: Quadrivalent human papillomavirus vaccine is targeted at HPV6, HPV11, HPV16, and HPV18. It is currently suitable for women aged 20 to 45 in China. The quadrivalent human papillomavirus vaccine is recommended to be administered once at 0, 2, and 6 months respectively. The three doses should be completed within one year.

3. Nine-valent human papillomavirus vaccine: The nine-valent human papillomavirus vaccine targets HPV6, HPV11, HPV16, HPV18, HPV31, HPV33, HPV45, HPV52, and HPV58. It is currently suitable for women between 9 and 45 years old. The vaccination procedures and requirements are the same as those for the quadrivalent human papillomavirus vaccine.

The incidence of cervical cancer is high and the mortality rate is gradually increasing. It is recommended that women learn about the human papillomavirus vaccine. Vaccination can be made at the local Center for Disease Control and Prevention, township health centers or community health service centers.